The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Pulmonary edema, noncardiogenic (NCPE)
Publications
A comparison of three tocolytics for preterm labor: a randomized clinical trial.
The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2014;27(8):801-6
[Non-invasive ventilation for pulmonary edema associated with tocolytic agents during labour for a twin pregnancy].
Canadian journal of anaesthesia = Journal canadien d'anesthesie. 2008;55(11):769-73
The pathophysiology of pulmonary oedema with the use of beta-agonists.
BJOG : an international journal of obstetrics and gynaecology. 2000;107(4):439-44
Severe pulmonary edema associated with tocolytic therapy. Case report with hemodynamic study.
Intensive care medicine. 1996;22(11):1280-1
Pulmonary edema associated with tocolytic therapy.
Annals of internal medicine. 1989;110(9):714-8
Chest case of the day. Pulmonary edema associated with tocolytic therapy.
AJR. American journal of roentgenology. 1992;158(6):1356-7